Intra-Subject Variabilities of Plasma GH Response to Human Growth Hormone-Releasing Hormone ( 1-44 ) NH 2 in Men
Mari,Hotta,Tamotsu,Shibasaki,Akitsugu,Masuda,T. Imaki,Ichiji,Wakabayashi,Hiroshi,Demura,Nicholas,Ling,Kazuo,Shizume
Abstract:The effects of intravenously given human growth hormone-releasing hormone (1-44) NH2 (hGRH-44) on growth hormone (GH) secretion were studied in normal men. A wide variability of intersubject GH response to hGRH-44 was observed. The peak plasma GH levels in response to 50, 100 and 200ƒÊg hGRH-44 in 7 normal men were 9.1•}3.2ng/ml (Mean+SEM), 19.3•}3.3ng/ml and 22.4•}4.0 ng/ml, respectively. Both the mean peak values for plasma GH response to 100 and 200ƒÊg were significantly greater than that for 50ƒÊg hGRH-44 injection (p<0.01), although there was no significant difference of the mean peak plasma GH values and mean concentrations at each time point, except for those at 120min, when 100 or 200ƒÊg hGRH-44 was administered. A significant difference in the mean amount of plasma GH secreted in response to hGRH-44 was observed only between 50 and 200ƒÊg hGRH-44 injection (p<0.01). Furthermore, a dose-related plasma GH increase in response to hGRH-44 was not always observed in each subject. In contrast to the wide intersubject variability, the difference among responses of plasma GH to 100ƒÊg or 200ƒÊg of hGRH-44 given at multiple times separated by intervals of at least 1 week in each individual was relatively small. These results suggest that the wide intersubject variability could cause no dose-related GH response to hGRH-44 in doses of 50, 100 and 200ƒÊg and that the intrasubject variability was small enough to evaluate the GH secretion by a single hGRH-44 injection, a procedure not adopted before. Three peptides with growth hormonereleasing activity were originally isolated from human pancreas tumors that had caused acromegaly. Amino acid sequence determination showed that they were closely related in structure and contained 37, 40 and 44 residues, respectively (Guillemin et al., 1982, Rivier et al., 1982). Recently human Received May 2, 1985 674 HOTTA et al. Endocrinol. Japon. October 1985 hypothalamic growth hormone-releasing hormones (hGRHs) were shown to be identical to 44 and 40 residue GH releasing peptides isolated from pancreas tumors (Ling et al., 1984). Human GRHs have been demonstrated to be specific and potent secretagogues for GH release in normal human (Thorner et al., Gelato et al., 1983; Shibasaki et al., 1984a, Vance et al., Gelato et al., 1984). However, the dose-related plasma GH response to hGRH injection was still controversial (Rosenthal et al., Wood et al., 1983; Vance et al., Gelato et al., 1984). These papers indicated the intersubject variability of plasma GH response to hGRH (Thorner et al., Gelato et al., Rosenthal et al., Wood et al., 1983, Vance et al., 1984), but there was no report in which the intrasubject variability of plasma GH response to hGRH was studied. This prompted us to examine intra and intersubject variabilities of plasma GH response to a single dose of hGRH-44 in healthy men in order to confirm the reliability of hGRH injection test in evaluating GH secretion. Subjects and Methods